The pharma and life sciences sector is entering a period defined by strategic collaboration, capability expansion, and scientific innovation. This edition highlights initiatives that demonstrate how organisations are responding to evolving healthcare demands and global market dynamics.

'Rentschler Biopharma and Coriolis Pharma form strategic collaboration' illustrates how partnerships can accelerate biopharmaceutical development and strengthen innovation pipelines. That momentum sets the stage for the 2026 awards, signalling continued focus on collaborative growth across the sector.

In addition, 'Unlocking Scientific Capability with SGS Insourcing' highlights how internal capability expansion can enhance research agility and operational excellence. The initiative underscores the strategic value of strengthening scientific infrastructure to meet rising industry demands.

Meanwhile, Highlighting the sector’s top innovators, the 'Video Highlights of the Pharma Industry Awards 2025’ celebrate organisations and professionals driving research, operational excellence, and patient-focused initiatives, setting benchmarks for collaboration and impact and paving the way for the next wave of achievement at the 2026 awards.

These stories illustrate a sector embracing collaboration, capability, and innovation. Organisations integrating these principles are positioned to deliver transformative, future-ready outcomes in pharma and life sciences.